Schizophrenia Clinical Trials in Chicago

Showing 21-40 of 118 trials

7-week Study With CT-155 in People With Schizophrenia

NCT05486312

CT-155 is a novel prescription digital therapeutic (PDT) to treat schizophrenia

Click Therapeutics, Inc.72 participantsStarted Jul 2022

Culver City, California, United States • Garden Grove, California, United States • La Habra, California, United States +7 more locations

COMPLETEDPhase 32.2 miles

A Study of Paliperidone Palmitate 6-Month Formulation

NCT03345342

The purpose of this study is to demonstrate that injection cycles consisting of a single administration of paliperidone palmitate 6-month (PP6M) are not less effective than 2 sequentially administered injections of paliperidone palmitate 3-month PP3M) (350 or 525 mg eq.) for the prevention of relapse in participants with schizophrenia previously stabilized on corresponding doses of paliperidone palmitate 1-month (PP1M) (100 or 150 mg eq.) or PP3M (350 or 525 mg eq.).

Schizophrenia

Janssen Research & Development, LLC841 participantsStarted Nov 2017

Rogers, Arkansas, United States • Anaheim, California, United States • Costa Mesa, California, United States +135 more locations

7-week Study With CT-155 in People With Schizophrenia

A Study of Paliperidone Palmitate 6-Month Formulation

Schizophrenia Trials in Other Cities

High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

Lumateperone for the Prevention of Relapse in Patients With Schizophrenia

An Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4)

Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831

A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms

Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder

This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Relative Bioavailability of LY03010 Compared to Listed Drug

A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS)

Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia

Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder

Trial to Study the Effect of CVL-231 on 24-Hour Ambulatory Blood Pressure in Participants With Schizophrenia

A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia

Observational Study of Long Acting Injectable Medications (LAIs) in Schizophrenia (OASIS)

Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia

Relapse Prevention Study in Patients With Schizophrenia

Other Conditions in Chicago